Results 131 to 140 of about 401,011 (182)
Kidney carcinoma associated with Xp11.2 translocation / TFE3 (ASPL-TFE3) gene fusion
, 2017 We report the case of a 58-year old patient, showing a solid image in the right kidney, who underwent radical nephrectomy that revealed neoplasia, whose pathological study led to the diagnosis of kidney carcinoma associated with Xp11.2 translocation ...
Soto Jr, Mario, Salles, Paulo G. O.
core
CT/MRI features of renal carcinomas associated with Xp11.2 translocation/TFE3 gene fusions
肿瘤影像学, 2018 Objective: To investigate the imaging features of renal carcinomas associated with Xp11.2 translocation/TFE3 gene fusions (Xp11.2/TFE RCC). Methods: The imaging data of 14 patients with Xp11.2/TFE RCC confirmed by operation and biopsy were analyzed ...
WANG Lu, XU Pengju, ZHU Mingming
doaj
Frontiers in OncologyBackgroundTFE3-rearranged renal cell carcinoma (TFE3-RCC) is a rare RCC subtype driven by translocation involving Xp11.2 and TFE3 gene fusion. The management of TFE3-RCC is similar to that of other RCC subtypes and primarily involves surgical resection ...
Biao Jiang +3 more
doaj +1 more source
Recent Advances in Renal Cell Carcinoma Associated with Xp11.2 Translocations/TFE Gene Fusions [PDF]
, 2012 Renal cell carcinoma associated with Xp11.2 translocations/TFE gene fusions (Xp11.2 RCC) has been classified as a distinct entity in the 2004 WHO classification of kidney tumors.
Chen, MD, PhD, Frank +2 more
core
Imaging hallmark of Xp11.2 translocation renal cell carcinoma
Canadian Urological Association Journal, 2015 Binit, Sureka +2 more
openaire +3 more sources
, 2019 Additional file 1. Characteristics of patients with Xp11.2/TFE3 RCC.
Pengfei Huang (552512) +7 more
core +1 more source
Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions（Xp11.2 RCC）
Renal cell carcinoma associated with Xp11.2 translocations/TFE3 gene fusions（Xp11.2 RCC）第353回東京女子医科大学学会例会 平成28年2月27日(土) 東京女子医科大学総合外来センター5階 ...
openaire +1 more source
The association between metabolic syndrome and renal cell carcinoma
Zhongguo aizheng zazhi, 2016 Background and purpose: The association between metabolic syndrome (MS) and renal cell carcinoma (RCC) is still unknown. The aim of this study was to elucidate how MS correlates with the prevalence and malignancy of RCC.
李 慧, 王弘恺, 顾伟杰
doaj